Head to Head Contrast: CVS Health (NYSE:CVS) & Cannlabs (OTCMKTS:CANL)

CVS Health (NYSE:CVS) and Cannlabs (OTCMKTS:CANL) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their profitability, institutional ownership, earnings, risk, valuation, analyst recommendations and dividends.

Analyst Ratings

This is a summary of current ratings and recommmendations for CVS Health and Cannlabs, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CVS Health	0	4	22	0	2.85
Cannlabs	0	0	0	0	0.00

CVS Health presently has a consensus target price of $96.12, suggesting a potential upside of 4.23%. Given CVS Health’s stronger consensus rating and higher probable upside, equities analysts plainly believe CVS Health is more favorable than Cannlabs.

Profitability

This table compares CVS Health and Cannlabs’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
CVS Health	0.72%	11.88%	3.54%
Cannlabs	N/A	N/A	N/A

Institutional & Insider Ownership

80.7% of CVS Health shares are owned by institutional investors. 0.9% of CVS Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Volatility & Risk

CVS Health has a beta of 0.6, meaning that its stock price is 40% less volatile than the S&P 500. Comparatively, Cannlabs has a beta of 1.54, meaning that its stock price is 54% more volatile than the S&P 500.

Earnings & Valuation

This table compares CVS Health and Cannlabs”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CVS Health	$402.07 billion	0.29	$1.77 billion	$2.27	40.63
Cannlabs	N/A	N/A	N/A	N/A	N/A

CVS Health has higher revenue and earnings than Cannlabs.

Summary

CVS Health beats Cannlabs on 9 of the 10 factors compared between the two stocks.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail order pharmacy, clinical, disease management, and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, CMS, plans offered on public health insurance, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, LTC pharmacies and on-site pharmacies, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was incorporated in 1996 and is headquartered in Woonsocket, Rhode Island.

About Cannlabs

CannLabs, Inc. provides cannabis testing laboratory services in the United States. Its testing services include potency testing, residual solvent analysis, microbiological testing, pesticide testing, heavy metals testing, nutrient analysis, terpenes analysis, shelf-life/stability studies, gene expression testing, and genotyping/phenotyping testing. The company also offers data/analytics and consulting, as well as education services. CannLabs, Inc. was incorporated in 2010 and is based in Denver, Colorado.